AIS Biotech is a company headquartered in France. Brouky records 1 investor associated with the company.
Developing a new antiviral molecule intended to treat influenza (an anti‑flu therapeutic).
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.